Rapid Micro Biosystems, Inc.
RPID
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.65% | -29.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.65% | -29.07% | |||
| Cost of Revenue | -10.34% | -34.27% | |||
| Gross Profit | 226.68% | 213.11% | |||
| SG&A Expenses | -6.09% | 25.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.76% | -6.98% | |||
| Operating Income | 11.05% | -13.44% | |||
| Income Before Tax | 9.74% | -14.29% | |||
| Income Tax Expenses | 462.50% | -42.86% | |||
| Earnings from Continuing Operations | 9.47% | -14.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.47% | -14.23% | |||
| EBIT | 11.05% | -13.44% | |||
| EBITDA | 11.40% | -13.12% | |||
| EPS Basic | 14.93% | -12.17% | |||
| Normalized Basic EPS | 15.18% | -12.24% | |||
| EPS Diluted | 14.93% | -12.17% | |||
| Normalized Diluted EPS | 15.18% | -12.24% | |||
| Average Basic Shares Outstanding | 6.41% | 1.83% | |||
| Average Diluted Shares Outstanding | 6.41% | 1.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||